Tasigna Capsules 200mg from Novartis Pharma contain Nilotinib hydrochloride hydrate, a kinase inhibitor used for treating Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML). This 200mg x 1 capsule formulation has a YJ code of 4291021M1020.
Tasigna Capsules 200mg
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).
